Document is current
Any future updates will be listed below
-
Authors
Gehmeyr, Manuel
Rojas López, María Begoña
Nitkunanantharajah, Suhanyaa
Preißl, Hubert
Vosseler, Andreas
Schwartzenberg, Reiner Jumpertz von
Birkenfeld, Andreas L.
Katsouli, Nikoletta
Fasoula, Nikolina-Alexia
Karlas, Angelos
Kallmayer, Michael
Ziegler, Anette-Gabriele
Jüstel, Dominik
Ntziachristos, Vasilis
-
Funding
Funding for this research was provided by:
Deutsches Zentrum für Diabetesforschung (01GI0925, 01GI0925, 01GI0925, 01GI0925)
Horizon 2020 Framework Programme (No 101017802 (OPTOMICS), No 101017802 (OPTOMICS))
Deutsches Zentrum für Herz-Kreislaufforschung (FKZ 81Z0600104, FKZ 81Z0600104)
Federal Ministry of Research, Technology and Space (TEKIOS (grant number: 03VP102070))
- License Information
-
More Information
Article History
Received: 21 February 2025
Accepted: 16 September 2025
First Online: 6 October 2025
Competing interests
: V.N. is a founder and equity owner of Maurus OY, sThesis GmbH, iThera Medical GmbH, Spear UG and I3 Inc. All other authors declare no financial competing interests. All authors declare no competing non-financial interests.
